loader2
Partner With Us NRI

Jun 28, 2024

Category

Others

AUM (Cr.)

552.77

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.21

Sharpe Ratio

21.82

Beta Ratio

0.00

Fund Manager

Himanshu Mange

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Invest Now
Nifty Pharma TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF 2.67 17.15 45.57 0 0 11.74
Benchmark - Nifty Pharma TRI 2.69 17.32 45.98 12.32 20.56 0
Category Average - BEST ETFS/INDEX 3.4 14.33 33.63 16.19 16.51 20.34
Category Rank 4/1 1/1 1/1 3/1 2/1 1/1
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
HDFC Silver ETF 84.5520 1.50 24.32 0.00 0.00 195.97 0.40 500.00 invest
AXIS Silver ETF 88.3960 1.49 25.89 0.00 0.00 113.83 0.35 500.00 invest
Tata Silver ETF 8.6953 1.16 0.00 0.00 0.00 69.13 0.00 100.00 invest
ICICI Pru Nifty Healthcare ETF 127.6671 1.10 42.67 13.67 0.00 114.00 0.15 1,000.00 invest
DSP Nifty Private Bank ETF 26.2284 -1.11 0.00 0.00 0.00 75.56 0.00 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. May 31, 2024 135.08 24.44 -15.22
Equity-Cipla May 31, 2024 65.09 11.77 -9.82
Equity-Dr Reddy`s Labs May 31, 2024 60.45 10.94 -18.56
Equity-Divi`s Lab. May 31, 2024 47.05 8.51 -6.10
Equity-Lupin May 31, 2024 32.75 5.92 -16.12
Equity-Aurobindo Pharma May 31, 2024 28.58 5.17 -10.33
Equity-Zydus Lifesci. May 31, 2024 21.69 3.92 -8.49
Equity-Torrent Pharma. May 31, 2024 21.10 3.82 -11.02
Equity-Alkem Lab May 31, 2024 20.68 3.74 -13.24
Equity-Glenmark Pharma. May 31, 2024 14.88 2.69 -4.24

latest news

Nippon India MF Announces change in scheme name

Nippon India Mutual Fund has announced change in scheme name under the foll...

Jun 15, 2024 12:10

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 June 2024 as the record date for ...

Jun 11, 2024 09:37

Nippon MF Announces change in scheme name

Nippon India Mutual Fund has announced change in scheme name under the foll...

Jun 01, 2024 14:23

Nippon Mutual Fund Announces change in benchmark under its schemes

Nippon Mutual Fund has announced change the benchmark index for the followi...

Jun 01, 2024 13:38

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 May 2024 as the record date for d...

May 10, 2024 09:09

Nippon India MF Announces change in fund managers under its schemes

Nippon India Mutual Fund has announced the following change in the fund man...

May 02, 2024 14:54

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Himanshu Mange
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com